Venetoclax ex vivo functional profiling predicts improved progression-free survival
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2022-08-01
|
| Series: | Blood Cancer Journal |
| Online Access: | https://doi.org/10.1038/s41408-022-00710-9 |
| _version_ | 1811315063441588224 |
|---|---|
| author | Vikas A. Gupta Shannon M. Matulis Benjamin G. Barwick R. Devin Bog Conrad W. Shebelut Mala Shanmugam Paola Neri Nizar J. Bahlis Madhav V. Dhodapkar Leonard T. Heffner Craig C. Hofmeister Nisha S. Joseph Sagar Lonial Jonathan L. Kaufman David L. Jaye Ajay K. Nooka Lawrence H. Boise |
| author_facet | Vikas A. Gupta Shannon M. Matulis Benjamin G. Barwick R. Devin Bog Conrad W. Shebelut Mala Shanmugam Paola Neri Nizar J. Bahlis Madhav V. Dhodapkar Leonard T. Heffner Craig C. Hofmeister Nisha S. Joseph Sagar Lonial Jonathan L. Kaufman David L. Jaye Ajay K. Nooka Lawrence H. Boise |
| author_sort | Vikas A. Gupta |
| collection | DOAJ |
| first_indexed | 2024-04-13T11:23:36Z |
| format | Article |
| id | doaj.art-b80806186ba7462e812a4322e8cf5287 |
| institution | Directory Open Access Journal |
| issn | 2044-5385 |
| language | English |
| last_indexed | 2024-04-13T11:23:36Z |
| publishDate | 2022-08-01 |
| publisher | Nature Publishing Group |
| record_format | Article |
| series | Blood Cancer Journal |
| spelling | doaj.art-b80806186ba7462e812a4322e8cf52872022-12-22T02:48:45ZengNature Publishing GroupBlood Cancer Journal2044-53852022-08-011281410.1038/s41408-022-00710-9Venetoclax ex vivo functional profiling predicts improved progression-free survivalVikas A. Gupta0Shannon M. Matulis1Benjamin G. Barwick2R. Devin Bog3Conrad W. Shebelut4Mala Shanmugam5Paola Neri6Nizar J. Bahlis7Madhav V. Dhodapkar8Leonard T. Heffner9Craig C. Hofmeister10Nisha S. Joseph11Sagar Lonial12Jonathan L. Kaufman13David L. Jaye14Ajay K. Nooka15Lawrence H. Boise16Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Emory University School of MedicineDepartment of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Emory University School of MedicineDepartment of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Emory University School of MedicineDepartment of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Emory University School of MedicineDepartment of Pathology and Laboratory Medicine, Winship Cancer Institute of Emory University, Emory University School of MedicineDepartment of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Emory University School of MedicineArnie Charbonneau Cancer Research Institute, University of CalgaryArnie Charbonneau Cancer Research Institute, University of CalgaryDepartment of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Emory University School of MedicineDepartment of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Emory University School of MedicineDepartment of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Emory University School of MedicineDepartment of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Emory University School of MedicineDepartment of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Emory University School of MedicineDepartment of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Emory University School of MedicineDepartment of Pathology and Laboratory Medicine, Winship Cancer Institute of Emory University, Emory University School of MedicineDepartment of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Emory University School of MedicineDepartment of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Emory University School of Medicinehttps://doi.org/10.1038/s41408-022-00710-9 |
| spellingShingle | Vikas A. Gupta Shannon M. Matulis Benjamin G. Barwick R. Devin Bog Conrad W. Shebelut Mala Shanmugam Paola Neri Nizar J. Bahlis Madhav V. Dhodapkar Leonard T. Heffner Craig C. Hofmeister Nisha S. Joseph Sagar Lonial Jonathan L. Kaufman David L. Jaye Ajay K. Nooka Lawrence H. Boise Venetoclax ex vivo functional profiling predicts improved progression-free survival Blood Cancer Journal |
| title | Venetoclax ex vivo functional profiling predicts improved progression-free survival |
| title_full | Venetoclax ex vivo functional profiling predicts improved progression-free survival |
| title_fullStr | Venetoclax ex vivo functional profiling predicts improved progression-free survival |
| title_full_unstemmed | Venetoclax ex vivo functional profiling predicts improved progression-free survival |
| title_short | Venetoclax ex vivo functional profiling predicts improved progression-free survival |
| title_sort | venetoclax ex vivo functional profiling predicts improved progression free survival |
| url | https://doi.org/10.1038/s41408-022-00710-9 |
| work_keys_str_mv | AT vikasagupta venetoclaxexvivofunctionalprofilingpredictsimprovedprogressionfreesurvival AT shannonmmatulis venetoclaxexvivofunctionalprofilingpredictsimprovedprogressionfreesurvival AT benjamingbarwick venetoclaxexvivofunctionalprofilingpredictsimprovedprogressionfreesurvival AT rdevinbog venetoclaxexvivofunctionalprofilingpredictsimprovedprogressionfreesurvival AT conradwshebelut venetoclaxexvivofunctionalprofilingpredictsimprovedprogressionfreesurvival AT malashanmugam venetoclaxexvivofunctionalprofilingpredictsimprovedprogressionfreesurvival AT paolaneri venetoclaxexvivofunctionalprofilingpredictsimprovedprogressionfreesurvival AT nizarjbahlis venetoclaxexvivofunctionalprofilingpredictsimprovedprogressionfreesurvival AT madhavvdhodapkar venetoclaxexvivofunctionalprofilingpredictsimprovedprogressionfreesurvival AT leonardtheffner venetoclaxexvivofunctionalprofilingpredictsimprovedprogressionfreesurvival AT craigchofmeister venetoclaxexvivofunctionalprofilingpredictsimprovedprogressionfreesurvival AT nishasjoseph venetoclaxexvivofunctionalprofilingpredictsimprovedprogressionfreesurvival AT sagarlonial venetoclaxexvivofunctionalprofilingpredictsimprovedprogressionfreesurvival AT jonathanlkaufman venetoclaxexvivofunctionalprofilingpredictsimprovedprogressionfreesurvival AT davidljaye venetoclaxexvivofunctionalprofilingpredictsimprovedprogressionfreesurvival AT ajayknooka venetoclaxexvivofunctionalprofilingpredictsimprovedprogressionfreesurvival AT lawrencehboise venetoclaxexvivofunctionalprofilingpredictsimprovedprogressionfreesurvival |